novolimus
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
To date, experience with bioresorbable scaffolds (BRS) that elute agents other than everolimus is limited. Thus, a post‐marketing…
Bioresorbable coronary scaffolds (BRS) have been developed to increase the late safety of coronary angioplasty by providing…
AIMS
Newer-generation drug-eluting stents (DES) have been shown to be superior to first-generation DES. Current-generation DES…
Patients listed for organ transplant frequently have severe coronary artery disease (CAD), which may be treated with drug eluting…
AIMS
Novolimus, a macrocyclic lactone with anti-proliferative properties, has a similar efficacy to currently available agents…
Owing to their marked efficacy in reducing restenosis, drug-eluting stents currently represent the predominant strategy for…
AIMS
First generation DES have markedly reduced restenosis. However, there is a major interest in developing new DES with greater…